Cargando…
Interferon-γ induces interleukin-6 production by neutrophils via the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway
OBJECTIVE: Interferon-gamma (IFN-γ) is overexpressed in rheumatoid synovium and thought to be involved in the pathogenesis of rheumatoid arthritis (RA). In this study, we examined our hypothesis that IFN-γ activates innate immune cells and upregulates inflammatory cytokines. Peripheral blood neutrop...
Autores principales: | Yoshida, Shuhei, Yamada, Shunya, Yokose, Kohei, Matsumoto, Haruki, Fujita, Yuya, Asano, Tomoyuki, Matsuoka, Naoki, Temmoku, Jumpei, Sato, Shuzo, Yoshiro-Furuya, Makiko, Watanabe, Hiroshi, Migita, Kiyoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666078/ https://www.ncbi.nlm.nih.gov/pubmed/34895310 http://dx.doi.org/10.1186/s13104-021-05860-w |
Ejemplares similares
-
Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022) -
Drug Retention Rates and the Safety of Janus Kinase Inhibitors in Elderly Patients with Rheumatoid Arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2023) -
JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
por: Fujita, Yuya, et al.
Publicado: (2020) -
Association between inflammatory cytokines and immune–checkpoint molecule in rheumatoid arthritis
por: Matsumoto, Haruki, et al.
Publicado: (2021) -
Drug Retention Rates of Janus Kinase Inhibitors in Rheumatoid Arthritis Patients with Therapy-Induced Lymphopenia
por: Temmoku, Jumpei, et al.
Publicado: (2023)